Glycemic Disorder Risk Remote Monitoring Program in the COVID-19 Very Elderly Patients: Preliminary Results.
Abrar-Ahmad Zulfiqar,Delwende Noaga Damien Massimbo,Mohamed Hajjam,Bernard Geny,Samy Talha,Jawad Hajjam,Sylvie Ervé,Amir Hajjam El Hassani,Emmanuel Andrès +8 more
TLDR
In this paper, the authors used the smart MyPrediTM e-platform to automatically detect the exacerbation of glycemic disorder risk in COVID-19 older diabetic patients.Abstract:
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. This was the basis for the “GER-e-TEC COVID study,” an experiment involving the use of the smart MyPrediTM e-platform to automatically detect the exacerbation of glycemic disorder risk in COVID-19 older diabetic patients.
Methods: The MyPrediTM platform is connected to a medical analysis system that receives physiological data from medical sensors in real time and analyzes this data to generate (when necessary) alerts. An experiment was conducted between December 14th, 2020 and February 25th, 2021 to test this alert system. During this time, the platform was used on COVID-19 patients being monitored in an internal medicine COVID-19 unit at the University Hospital of Strasbourg. The alerts were compiled and analyzed in terms of sensitivity, specificity, positive and negative predictive values with respect to clinical data.
Results: 10 older diabetic COVID-19 patients in total were monitored remotely, six of whom were male. The mean age of the patients was 84.1 years. The patients used the telemedicine solution for an average of 14.5 days. 142 alerts were emitted for the glycemic disorder risk indicating hyperglycemia, with an average of 20.3 alerts per patient and a standard deviation of 26.6. In our study, we did not note any hypoglycemia, so the system emitted any alerts. For the sensitivity of alerts emitted, the results were extremely satisfactory, and also in terms of positive and negative predictive values. In terms of survival analysis, the number of alerts and gender played no role in the length of the hospital stay, regardless of the reason for the hospitalization (COVID-19 management).
Conclusion: This work is a pilot study with preliminary results. To date, relatively few projects and trials in diabetic patients have been run within the “telemedicine 2.0” setting, particularly using AI, ICT and the Web 2.0 in the era of COVID-19 disease.read more
References
More filters
Journal ArticleDOI
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Lihua Zhu,Zhi-Gang She,Xu Cheng,Juan Juan Qin,Xiao Jing Zhang,Jingjing Cai,Fang Lei,Haitao Wang,Jing Xie,Wenxin Wang,Haomiao Li,Peng Zhang,Xiaohui Song,Xi Chen,Xiang Mei,Chaozheng Zhang,Liangjie Bai,Da Xiang,Ming Ming Chen,Yanqiong Liu,Youqin Yan,Mingyu Liu,Weiming Mao,Jinjing Zou,Liming Liu,Guohua Chen,Pengcheng Luo,Bing Xiao,Changjiang Zhang,Zixiong Zhang,Zhigang Lu,Junhai Wang,Haofeng Lu,Xigang Xia,Daihong Wang,Xiaofeng Liao,Gang Peng,Ping Ye,Jun Yang,Yufeng Yuan,Xiaodong Huang,Jiao Guo,Bing Hong Zhang,Hongliang Li +43 more
TL;DR: Clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D is provided, associated with markedly lower mortality compared to individuals with poorly controlled BG during hospitalization.
Journal ArticleDOI
Telemonitoring in Patients with Heart Failure
Sarwat I. Chaudhry,Jennifer A. Mattera,Jeptha P. Curtis,John A. Spertus,Jeph Herrin,Zhenqiu Lin,Christopher O. Phillips,Beth Hodshon,Lawton S. Cooper,Harlan M. Krumholz +9 more
TL;DR: Among patients recently hospitalized for heart failure, telemonitoring did not improve outcomes, and the results indicate the importance of a thorough, independent evaluation of disease-management strategies before their adoption.
Journal ArticleDOI
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic,Piotr Ponikowski,Stefan D. Anker,Johann Bauersachs,Ovidiu Chioncel,John G.F. Cleland,John G.F. Cleland,Rudolf A. de Boer,Heinz Drexel,Tuvia Ben Gal,Tuvia Ben Gal,Loreena Hill,Tiny Jaarsma,Ewa A. Jankowska,Markus S. Anker,Mitja Lainscak,Basil S. Lewis,Theresa McDonagh,Marco Metra,Davor Miličić,Wilfried Mullens,Massimo F Piepoli,Giuseppe M.C. Rosano,Frank Ruschitzka,Maurizio Volterrani,Adriaan A. Voors,Gerasimos Filippatos,Gerasimos Filippatos,Andrew J.S. Coats +28 more
TL;DR: This expert consensus report is neither a guideline update nor a position statement, but rather a summary and consensus view in the form of consensus recommendations.
Journal ArticleDOI
Telemedicine and remote management of patients with heart failure
TL;DR: It is optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure and standardisation and appropriate classification of telemedical systems are needed to enable accurate interpretation of clinical trials.
Journal ArticleDOI
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)
Guillaume Charpentier,Pierre-Yves Benhamou,Dured Dardari,Annie Clergeot,Sylvia Franc,Pauline Schaepelynck-Belicar,Bogdan Catargi,V. Melki,Lucy Chaillous,Anne Farret,Jean-Luc Bosson,Alfred Penfornis +11 more
TL;DR: The Diabeo system gives a substantial improvement to metabolic control in chronic, poorly controlled type 1 diabetic patients without requiring more medical time and at a lower overall cost for the patient than usual care.